已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Cancer IDO1‐Mediated Tryptophan–Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration

医学 恶病质 癌症恶病质 肌肉萎缩 骨骼肌 癌症 萎缩 重编程 癌症研究 肌萎缩 合成代谢 生物信息学 癌症治疗 内分泌学 内科学 能量代谢 脂肪组织 癌细胞 能源消耗 肿瘤科
作者
Leng Han,LingJie Jing,Xinting Zhu,Ciqin Li,Lu Bai,Yang Fang,Yuxuan Zhou,Dingyuan Bai,Jin Lu,Yonglong Han,Cheng Guo,Shumin Zhou,Quanjun Yang
出处
期刊:Journal of Cachexia, Sarcopenia and Muscle [Springer Science+Business Media]
卷期号:17 (3): e70295-e70295 被引量:2
标识
DOI:10.1002/jcsm.70295
摘要

BACKGROUND: Cancer cachexia is a debilitating syndrome characterized by severe skeletal muscle wasting, which significantly impairs patient quality of life and survival. Indoleamine 2,3-dioxygenase 1 (IDO1), a key enzyme in tryptophan (Trp) metabolism, is often upregulated in cancers, but its specific role in driving lung cancer-associated cachexia remains inadequately defined. This study investigated the mechanistic role of Ido1 in cancer cachexia and evaluated the therapeutic potential of its inhibition. METHODS: We established Lewis lung carcinoma (LLC) models in C57BL/6 mice using wild-type, Ido1-overexpressing (Ido1-OE) and Ido1-knockout (Ido1-KO) cells. Muscle mass, tumour growth and metabolic changes were assessed in vivo. Transcriptomic and targeted metabolomic analyses were performed on muscle and serum samples. In vitro, we examined the effects of tumour-conditioned media, the Trp metabolite kynurenine (Kyn) and Trp supplementation on C2C12 myotube atrophy. In vivo experiments verified the efficacy of the Ido1 inhibitor palmatine hydrochloride (PAL). Molecular pathways were analysed via western blot and qPCR. RESULTS: Compared to LLC mouse models, Ido1-OE significantly exacerbated tumour growth and cachexia, leading to a significant decrease in lean body weight, gastrocnemius and tibialis anterior muscle weights (p < 0.01, p < 0.0001, p < 0.001). Gastrocnemius muscle fibre cross-sectional area significantly decreased in the Ido1-OE group (p < 0.0001). Transcriptomic analysis revealed that Ido1-OE activated pro-inflammatory and protein degradation pathways (upregulating MuRF1/Atrogin1, p < 0.05) while suppressing anabolic signalling pathways (oestrogen pathways, p < 0.01). Metabolomics analysis revealed unique metabolic signatures in Ido1-OE mice: Trp depletion and Kyn accumulation. In vitro experiments demonstrated that Ido1-OE enhanced LLC cell proliferation and migration capabilities (p < 0.0001, p < 0.0001). Tumour-conditioned medium (TCM) derived from Ido1-OE tumours significantly induced C2C12 myotube atrophy (p < 0.01). Similarly, direct treatment with Kyn led to dose-dependent muscle fibre shrinkage, with significant atrophy observed at 30 μM (p < 0.01) and 100 μM (p < 0.0001). Notably, the myotube atrophy induced by Kyn was significantly reversed by the addition of supplemental Trp (p < 0.0001). Compared with the Ido1-OE group, PAL treatment reduced gastrocnemius and tibialis anterior atrophy (p < 0.01; p < 0.05). Mechanistically, PAL inhibited the mRNA expression levels of MuRF1/Atrogin1 (p < 0.0001, p < 0.001), as well as their corresponding protein levels (p < 0.0001, p < 0.0001). Furthermore, PAL restored the phosphorylation level of mTOR (p < 0.001), as well as the mRNA expression of myosin heavy chain (p < 0.01). CONCLUSIONS: Our findings demonstrate that Ido1 accelerates muscle atrophy and cancer cachexia by driving a metabolic reprogramming centred on the Trp-Kyn pathway. Pharmacological inhibition of Ido1 with PAL effectively mitigates these effects, positioning Ido1 as a promising therapeutic target for treating cancer cachexia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
alex的应助被开放的小Q采纳,获得10
3秒前
小巧的面包完成签到 ,获得积分10
6秒前
飘逸小之发布了新的文献求助10
6秒前
陈陈潇完成签到,获得积分20
7秒前
7秒前
xr完成签到,获得积分10
8秒前
9秒前
踏实乐枫发布了新的文献求助10
12秒前
xr发布了新的文献求助10
13秒前
13秒前
14秒前
14秒前
15秒前
粗心的小鸽子完成签到,获得积分10
15秒前
跳跃的正豪完成签到,获得积分10
16秒前
yao发布了新的文献求助10
16秒前
gbh完成签到 ,获得积分20
18秒前
子皿发布了新的文献求助10
18秒前
ccccc完成签到 ,获得积分10
19秒前
moriaty发布了新的文献求助20
20秒前
自信的寄松完成签到 ,获得积分10
22秒前
专注的夜天完成签到,获得积分10
26秒前
gzghgzh完成签到,获得积分10
27秒前
菲菲完成签到 ,获得积分10
28秒前
科研通AI6.4的应助被开朗向彤采纳,获得10
29秒前
顾矜的应助被科研通管家采纳,获得10
30秒前
Owen的应助被科研通管家采纳,获得10
30秒前
彭于晏的应助被科研通管家采纳,获得10
30秒前
vc驳回了Maestro_S的应助
30秒前
桐桐的应助被科研通管家采纳,获得10
30秒前
JamesPei的应助被科研通管家采纳,获得10
30秒前
FashionBoy的应助被科研通管家采纳,获得10
31秒前
bkagyin的应助被科研通管家采纳,获得10
31秒前
31秒前
DW的应助被科研通管家采纳,获得10
31秒前
31秒前
31秒前
FashionBoy的应助被科研通管家采纳,获得10
31秒前
笙笙的应助被科研通管家采纳,获得10
31秒前
王世缘完成签到,获得积分10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184917
求助须知:如何正确求助?哪些是违规求助? 9573843
关于积分的说明 21833352
捐赠科研通 7782304
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558581
邀请新用户注册赠送积分活动 2481082